All News

Flu and Tofacitinib

Save

Nov 19, 2020

Dr. Kathryn Dao reviews abstract L04 - Influenza Adverse Events in Patients with Rheumatoid Arthritis in the Tofacitinib Clinical Program - at the 2020 ACR annual meeting.

Read Article

food healthy unhealthy beer alcohol salt

The folly of dietary restriction in contemporary gout?

Save

d Richard Conway, MBBChBAO, PhD

Nov 19, 2020

Gout has historically been considered a disease of the financially rich, rich in diet, and rich in alcohol.

Read Article

#BestARC20Tweets "RT @drdavidliew : Great to sit down with @LCalabreseDO @Sarah_L_Mackie @RichardPAConway a few hours ago and chat about two very interesting GCA therapeutics abstracts: https://t.co/V3fzB0W3Ko great discussion! #ACR20 @RheumNow"

Links:

https://bit.ly/3lMUpf3

Dr. John Cush RheumNow ( View Tweet)

Nov 20, 2020

Read our article titled: Best Imaging Techniques for non ANCA Vasculitis by Dr. Alexa Meara ( @lexmeara) as discussed at #ACR20 https://t.co/CyfC8bdq42 https://t.co/Ay7Sw0eMTY

Links:

https://bit.ly/3f147rE

Dr. John Cush RheumNow ( View Tweet)

Nov 20, 2020

What was your favorite abstract or study presented at #ACR20? We've rounded up our top choices. #ACRbest https://t.co/50hpUUSCBD https://t.co/09t2kziLQr

Links:

https://bit.ly/36CWowd

Dr. John Cush RheumNow ( View Tweet)

Nov 20, 2020

What is the SEAMless transition from combination Etanercept to Methotrexate? with Dr. Jonathan Kay #ACR20 https://t.co/58raeaE8Mr https://t.co/FUIidcoy4I

Links:

https://bit.ly/2Ivu32v

Dr. John Cush RheumNow ( View Tweet)

Nov 20, 2020

The #ACR20 convergence highlighted a shift in gout management and uric acid lowering therapy (ULT). Read more about mitigating immunogenicity when using uricase therapies as ULT in an article by Dr. Alexa Meara ( @lexmeara) https://t.co/5AfyFhJGqp https://t.co/Sv1BiI0Uwd

Links:

https://bit.ly/32NuxIN

Dr. John Cush RheumNow ( View Tweet)

Nov 20, 2020

Check out our article titled: FAST, FREED, CARES, & CONFIRMS: A Run-Down on the Black-Box Blues of Febuxostat by Dr. Meral K. El Ramahi ( @MeralElRamahiMD). #ACR20 https://t.co/dKhotXONGP https://t.co/KfsFFX7z0D

Links:

https://bit.ly/3pj6X04

Dr. John Cush RheumNow ( View Tweet)

Nov 19, 2020

Check out our video on representation of women authors in rheumatology: Dr Bella Mehta ( @bella_mehta) #ACR20 https://t.co/4EAiiSwye8 https://t.co/AS1P8IseJT

Links:

https://bit.ly/35ouSDo

Dr. John Cush RheumNow ( View Tweet)

Nov 19, 2020

Improving Drug Adherence in RA: Dr Janet Pope ( @Janetbirdope) Reviews abstract #799 presented at #ACR20. https://t.co/ONCJmCOdzC https://t.co/ornpQiopTS

Links:

https://bit.ly/3nirkbR

Dr. John Cush RheumNow ( View Tweet)

Nov 19, 2020

Great read! "The Vaccine Review Process and Why You Should Know It" by Dr. Rachel Tate ( @uptoTate) https://t.co/l39qH3LuXm https://t.co/PR1AaQCD7V

Links:

https://bit.ly/36KmZHA

Dr. John Cush RheumNow ( View Tweet)

Nov 19, 2020

SEAM-RA Trial: Dr. Jeff Curtis ( @RADoctor) discusses abstract # 0939 that looked at whether RA patients at or close to remission should continue taking their combination therapy, as presented at #ACR20 https://t.co/2yMyj4BKs1 https://t.co/2gqJM4EKpG

Links:

https://bit.ly/3krXcsD

Dr. John Cush RheumNow ( View Tweet)

Nov 19, 2020

Long-Term Benefits of Ixekizumab in Psoriatic Arthritis https://t.co/CaGVSvFzVd https://t.co/ktdG5nt96f

Links:

https://bit.ly/36ChTx7

Dr. John Cush RheumNow ( View Tweet)

Nov 19, 2020

PsA Studies: Entheses, Ultrasound, Swollen not Tender Joints: Dr. Antoni Chan ( @synovialjoints) #ACR20 https://t.co/S6Nj9eWnTF https://t.co/qDOT2TwfHl

Links:

https://bit.ly/38FiUHE

Dr. John Cush RheumNow ( View Tweet)

Nov 19, 2020

TNF Inhibitor Associated Infectious Risk Greatest in First 6 Months https://t.co/fMF71rMAn8 https://t.co/mlFFb2m4UE

Links:

https://bit.ly/35zb7cb

Dr. John Cush RheumNow ( View Tweet)

Nov 19, 2020

Dr. David Liew ( @drdavidliew) reviews abstracts #0431 on HCQ and QTc Prolongation as presented at #ACR20. https://t.co/vbqf7UNzVY https://t.co/qBCqFqYQCo

Links:

https://bit.ly/3poUZSB

Dr. John Cush RheumNow ( View Tweet)

Nov 19, 2020

Download our 2020 TNF Inhibitor Biosimilars worksheet. https://t.co/whebbA3Ucv https://t.co/Bm5rgBPKkH

Links:

https://bit.ly/32E16J5

Dr. John Cush RheumNow ( View Tweet)

Nov 19, 2020

#BestACR20Tweets RT @KDAO2011 : FDA updates 6/16/20 canakinumab for AOSD 5/29/20 ixekizumab for nr-AxSpa 80 mg q4wks 3/9/20 nintedanib for progressive ILD 1/29/20 and 6/16/20 secukinumab nr-axSpa 150 mg q4wks, AS 300 mg SQ q4weeks 1/17/20 belimumab label for black pts removed

Dr. John Cush RheumNow ( View Tweet)

Nov 19, 2020

Revisiting Day 1 of #ACR20. Watch our video on what to do with subclinical synovitis. https://t.co/ynSRjiAFPe https://t.co/XeeGohW8t5

Links:

https://bit.ly/3poZaOb

Dr. John Cush RheumNow ( View Tweet)

Nov 19, 2020

How are RA patients doing using telemedicine/virtual care? Dr. Janet Pope ( @Janetbirdope) weighs in. #ACR20 https://t.co/YffT28OwgY https://t.co/OvpBDwkyEp

Links:

https://bit.ly/32N6V6K

Dr. John Cush RheumNow ( View Tweet)

Nov 18, 2020

Topics

All News

Flu and Tofacitinib

Save

The folly of dietary restriction in contemporary gout?

Save

Do you get our email newsletter?

Flu and Tofacitinib Save

The folly of dietary restriction in contemporary gout? Save

Flu and Tofacitinib

Save

The folly of dietary restriction in contemporary gout?

Save